Zebing Li1, Zhongjing Lin1, Yisheng Zhong1, Xi Shen1. 1. Department of Ophthalmology, Ruijin Hospital, Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.
Abstract
BACKGROUND: Lymphoma with intraocular metastasis is an uncommon and serious disease. We describe a case of diffuse large B-cell lymphoma (DLBCL) with iris metastasis. Meanwhile, we refer to published case reports retrieved via a PubMed search to summarize this rare disease. CASE PRESENTATION: Glaucoma and uveitis symptoms were found in the left eye of a 50-year-old woman upon admission to the hospital. After treatment and pathological examination, the iris of her left eye was diagnosed with DLBCL. Given the patient's unfavorable treatment options in the local hospital, primary enucleation was offered as a therapeutic option. CONCLUSIONS: Iris metastasis of systemic lymphoma is an extremely rare ophthalmic disease with poor prognosis. Ophthalmologists should be able to definitively and differentially diagnose eye symptoms and pay attention to systemic conditions to provide a series of optimized treatments.
BACKGROUND: Lymphoma with intraocular metastasis is an uncommon and serious disease. We describe a case of diffuse large B-cell lymphoma (DLBCL) with iris metastasis. Meanwhile, we refer to published case reports retrieved via a PubMed search to summarize this rare disease. CASE PRESENTATION: Glaucoma and uveitis symptoms were found in the left eye of a 50-year-old woman upon admission to the hospital. After treatment and pathological examination, the iris of her left eye was diagnosed with DLBCL. Given the patient's unfavorable treatment options in the local hospital, primary enucleation was offered as a therapeutic option. CONCLUSIONS: Iris metastasis of systemic lymphoma is an extremely rare ophthalmic disease with poor prognosis. Ophthalmologists should be able to definitively and differentially diagnose eye symptoms and pay attention to systemic conditions to provide a series of optimized treatments.
Authors: Mandeep S Sagoo; Hemal Mehta; Andrew J Swampillai; Victoria M L Cohen; Sepideh Z Amin; P Nicholas Plowman; Sue Lightman Journal: Surv Ophthalmol Date: 2013-12-31 Impact factor: 6.048
Authors: Sanjay V Patel; David C Herman; Peter M Anderson; Naser J Al-Zein; Helmut Buettner Journal: J Pediatr Hematol Oncol Date: 2003-08 Impact factor: 1.289